Inhibikase Therapeutics, Inc. (IKT) Net income 2020–2025
Inhibikase Therapeutics, Inc. (IKT) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$48.3MFY2025 · since FY2020: -$2.8M → -$48.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$48.3M | -75.4% |
| FY2024 | -$27.5M | -44.6% |
| FY2023 | -$19.0M | -5.4% |
| FY2022 | -$18.1M | -22.1% |
| FY2021 | -$14.8M | -419.2% |
| FY2020 | -$2.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice